MorphoSys AG buy piccolo90
Start price
21.07.16
/
50%
€39.43
Target price
03.03.17
€58.62
Performance (%)
51.10%
End price
03.03.17
€59.57
Summary
This prediction ended on 03.03.17 with a price of €59.57. With a performance of 51.10% the BUY prediction by piccolo90 was a big success. piccolo90 has 50% into this predictionMorphoSys is a German biopharmaceutical company that develops innovative therapies for the treatment of cancer, autoimmune diseases, and other serious illnesses. The company specializes in developing monoclonal antibodies, which are highly specific and targeted therapies that recognize and bind to specific cancer cells or disease-causing proteins in the body. MorphoSys has a diverse pipeline of products in various stages of development, including several drugs that have shown promising results in clinical trials. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of over $4 billion.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| MorphoSys AG | -1.476% | -1.476% | 262.181% | -16.395% |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
Comments by piccolo90 for this prediction
In the thread Morphosys AG diskutieren